Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characterization of Breast Masses Incidentally Detected on Chest CT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02755779
Recruitment Status : Unknown
Verified April 2016 by Yoav Amitai, Tel Aviv Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : April 29, 2016
Last Update Posted : May 2, 2016
Sponsor:
Information provided by (Responsible Party):
Yoav Amitai, Tel Aviv Medical Center

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Although Computed tomography (CT) is not routinely used to evaluate beast masses, It is common to discover Incidental breast lesions on chest CT.

The goal of this study is to investigate the incidence and appearance of incidentally discovered breast masses on chest CT.


Condition or disease
Breast Cancer

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Characterization of Breast Masses Incidentally Detected on Chest CT - a Prospective Study
Study Start Date : June 2016
Estimated Primary Completion Date : June 2017
Estimated Study Completion Date : June 2017

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Patient enrollment [ Time Frame: One year ]
    Enrolling 100 patients with breast masses to study


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Woman over 18
Criteria

Inclusion Criteria:

  • Woman with incidentally discovered breast masses on chest CT

Exclusion Criteria:

  • Male gender
  • Known breast cancer
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02755779


Contacts
Layout table for location contacts
Contact: Yoav Amitai, Dr +972544771715 yoavslava@yahoo.com

Sponsors and Collaborators
Tel Aviv Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Yoav Amitai, Dr Sourasky medical center Tel aviv
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Yoav Amitai, Dr, Tel Aviv Medical Center
ClinicalTrials.gov Identifier: NCT02755779    
Other Study ID Numbers: 0067-16-TLV
First Posted: April 29, 2016    Key Record Dates
Last Update Posted: May 2, 2016
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No